US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Weight Loss Drugs

1,492.17

+31.152.13%

Number of Gainers:5

Number of Losers:2

Number of Flat:- -

PE:- -

High:1,493.70

Open:1,460.44

Low:1,460.44

Close:1,461.02

Loading ...

Amgen’s Strategic Growth Potential Bolstered by Promising MariTide Phase III Trials

Amgen Launches Two Phase 3 Trials for Obesity Drug MariTide

MT Newswires Live

German Court Rules Pfizer, BioNTech, Violated Moderna Covid-19 Vaccine Patent, Reuters Reports

Novo Nordisk launches $499 Wegovy cash option and home delivery

Novo Nordisk's Cheaper Wegovy Offering Is Bad News for Hims & Hers Stock -- Barrons.com

Why Novo Nordisk (NVO) Is Rising Today

Novo Nordisk Launches NovoCare Pharmacy to Ship Wegovy Doses to Users' Homes

Novo Nordisk Slashes Wegovy Price, Undercutting Hims & Hers Health

German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent

German Court Rules in Favour of Moderna in Patent Lawsuit Against BioNTech and Pfizer

THOMSON REUTERS

Court Rules Pfizer, BioNTech Must Pay "Appropriate" Damages and Compensation; Ruling Can Be Appealed

THOMSON REUTERS

Novo Nordisk Plunges 21% in 3 Months: Buy, Sell or Hold the Stock?

GM, Novo Nordisk, Marvell, CrowdStrike: Stocks to watch today

Novo Nordisk offers Wegovy at lowered cost, Hims & Hers Health shares fall

Novo Nordisk Launches Delivery Option Offering Lower-Priced Wegovy

MT Newswires Live

Kenvue Announces Three New Appointments to Board of Directors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4599/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1492.1732,"timestamp":1741208399999,"preClose":1461.0245,"halted":0,"volume":58200771,"delay":0,"changeRate":0.02132,"change":31.148682,"pbRate":11.821485,"amount":5513579718.723701,"amplitude":0.02276,"prevYearClose":1305.0607,"fiveDayClose":1473.773,"twentyDayClose":1354.5123,"turnoverRate":0.005514,"marketCap":1606807813984,"floatMarketCap":1490733575264,"peRate":42.075031},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1493.6967,"amplitude":0.02276,"preClose":1461.0245,"low":1460.4442,"pbRate":"11.821485","latestPrice":1492.1732,"volume":58200771,"delay":0,"open":1460.4442,"prevYearClose":1305.0607,"prevWeekClose":1482.1702,"prevMonthClose":1482.1702,"prevQuarterClose":1305.0607,"fiveDayClose":1473.773,"twentyDayClose":1354.5123,"sixtyDayClose":1441.3252,"secType":"PLATE","market":"US","turnoverRate":0.005514,"peRate":42.075031,"marketCap":1606807813984,"floatMarketCap":1490733575264,"timestamp":1741208399999,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":5,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:16,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517941055","title":"Amgen’s Strategic Growth Potential Bolstered by Promising MariTide Phase III Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2517941055","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517941055?lang=en_us&edition=fundamental","pubTime":"2025-03-06 00:26","pubTimestamp":1741191962,"startTime":"0","endTime":"0","summary":"Matt Phipps, an analyst from William Blair, has initiated a new Buy rating on Amgen (AMGN). Matt Phipps has given his Buy rating due to a combinati...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/amgens-strategic-growth-potential-bolstered-by-promising-maritide-phase-iii-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/amgens-strategic-growth-potential-bolstered-by-promising-maritide-phase-iii-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0868494617.USD","BK4599","BK4139","BK4566","AMGN","LU1983299246.USD","BK4534","LU0889565916.HKD","BK4533","BK4588","LU1057294990.SGD","III","LU1061106388.HKD","LU2242652126.USD","LU1023059063.AUD","BK4585","BK4134","LU0109394709.USD","LU0058720904.USD","IE00B4R5TH58.HKD","LU2242646821.SGD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU1571399168.USD","SG9999001440.SGD","LU0320765992.SGD","LU0122379950.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU0289739699.SGD","BK4581","IE0002141913.USD"],"gpt_icon":0},{"id":"2517510941","title":"Amgen Launches Two Phase 3 Trials for Obesity Drug MariTide","url":"https://stock-news.laohu8.com/highlight/detail?id=2517510941","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517510941?lang=en_us&edition=fundamental","pubTime":"2025-03-06 00:25","pubTimestamp":1741191954,"startTime":"0","endTime":"0","summary":"Amgen  has initiated two phase 3 trials for its obesity drug MariTide, the company's Head of Research and Development, Jay Bradner, said Wednesday at an investor conference.One of the trials is in people with obesity or overweight without type 2 diabetes, and is expected to enroll 3,500 people, Bradner said. The second trial is in people with obesity or overweight who have type 2 diabetes, with Amgen intending to enroll 999 patients, he added.The studies will test different dose levels, starting at a lower dose. Bradner said the primary endpoint is the change in baseline body weight at 72 weeks.Price: 313.79, Change: +1.60, Percent Change: +0.51","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B4R5TH58.HKD","AMGN","IE0009355771.USD","LU0122379950.USD","LU2112291526.USD","LU0868494617.USD","BK4139","LU1057294990.SGD","IE00BJT1NW94.SGD","BK4581","LU2242652126.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","LU0289739699.SGD","LU2242646821.SGD","IE00B2B36J28.USD","BK4588","BK4566","BK4533","IE0002141913.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4599","LU0320765992.SGD","LU0058720904.USD","BK4534","LU1571399168.USD","BK4585","LU1983299246.USD","SG9999001440.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2517194159","title":"German Court Rules Pfizer, BioNTech, Violated Moderna Covid-19 Vaccine Patent, Reuters Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2517194159","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517194159?lang=en_us&edition=fundamental","pubTime":"2025-03-06 00:21","pubTimestamp":1741191660,"startTime":"0","endTime":"0","summary":"-- A German court in Duesseldorf ruled that Pfizer and partner BioNTech broke a coronavirus vaccine patent held by Moderna, Reuters reports.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","BK4599","LU1066053197.SGD","BK4533","PFE","BK4581","LU0985481810.HKD","LU1057294990.SGD","LU1894683348.USD","BK4592","LU1883839398.USD","IE00BLSP4452.SGD","SG9999001176.SGD","SG9999001176.USD","BK4585","BK4551","LU0321505868.SGD","SG9999003800.SGD","LU1023059063.AUD","LU0289739699.SGD","LU0058720904.USD","BK4532","IE00B19Z3581.USD","LU1066051498.USD","SG9999002232.USD","LU0868494617.USD","BNTX","SG9999002224.SGD","LU0234572021.USD","BK4007","BK4535","BK4550","LU0306806265.USD","SGXZ57979304.SGD","MRNA","BK4568","LU0321505439.SGD","BK4588","LU0122379950.USD","LU0456855351.SGD","IE00B19Z3B42.SGD","BK4501","BK4534","LU1894683264.USD","SG9999011175.SGD","LU0225771236.USD","SG9999013999.USD","BK4139","BK4548","LU0170899867.USD"],"gpt_icon":1},{"id":"2517949964","title":"Novo Nordisk launches $499 Wegovy cash option and home delivery","url":"https://stock-news.laohu8.com/highlight/detail?id=2517949964","media":"Yahoo Finance","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517949964?lang=en_us&edition=fundamental","pubTime":"2025-03-06 00:02","pubTimestamp":1741190548,"startTime":"0","endTime":"0","summary":"Novo Nordisk  announced a new cash-pay option for its blockbuster weight-loss drug Wegovy, offering a monthly dose at $499 and home delivery.The move follows competitor Eli Lilly , which similarly announced a $499 cash program for its weight-loss drug Zepbound.The two GLP-1 market leaders see the need to launch more access points to meet ongoing demand for the drugs. Especially after the FDA determined that their products, also known by their active ingredients — semaglutide for Wegovy and tirzepatide for Zepbound — are no longer in shortage, starting a countdown clock to unbranded knockoffs sold by compounding pharmacies.The new prices from both companies provide a 50% or more discount from the known list prices. Wegovy, for example, is listed for around $1,350 per month. but most patients pay less depending on their insurance coverage.Novo Nordisk's stock jumped more than 4% following the news Wednesday.Click here for in-depth analysis of the latest health industry news and events im","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novo-nordisk-launches-499-wegovy-cash-option-and-home-delivery-160228264.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4599","LU2324357040.USD","LU1804176565.USD","BK4532","LU0096364046.USD","LU2237443622.USD","LU2063271972.USD","LU2089984988.USD","LU0456855351.SGD","LU2237438978.USD","LU0320765059.SGD","LU1057294990.SGD","IE00BJLML261.HKD","LU1064131342.USD","SG9999015986.USD","LU2468319806.SGD","LU1023059063.AUD","LU1291159041.SGD","LU1720051108.HKD","LU1988902786.USD","LU0708995401.HKD","LU2361045086.USD","LU1868836914.USD","LU0058720904.USD","LLY","LU1548497426.USD","IE0004445239.USD","LU0640476718.USD","LU0061475181.USD","LU0094547139.USD","SG9999017495.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0097036916.USD","LU2265009873.SGD","LU0385154629.USD","BK4516","LU0354030511.USD","NVO","IE00BFTCPJ56.SGD","LU0820561909.HKD","LU1868836757.USD","SGXZ31699556.SGD","LU0154236417.USD","LU1974910355.USD","SG9999014880.SGD","BK4581","LU0943347566.SGD","LU1093756325.SGD","LU0203201768.USD"],"gpt_icon":1},{"id":"2517496009","title":"Novo Nordisk's Cheaper Wegovy Offering Is Bad News for Hims & Hers Stock -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2517496009","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517496009?lang=en_us&edition=fundamental","pubTime":"2025-03-05 23:56","pubTimestamp":1741190160,"startTime":"0","endTime":"0","summary":"The drugmaker Novo Nordisk has landed a solid blow against Hims & Hers Health, as Novo looks to recapture the patients it lost to companies selling legal knockoff versions of its weight-loss drug Wegovy.Novo Nordisk said Wednesday it will sell Wegovy at lower prices to uninsured patients and to patients whose insurance doesn't cover the medicine, through its own online pharmacy.The announcement comes weeks after the Food and Drug Administration declared that Wegovy is no longer in shortage. That means Hims will have to stop selling its copycat version of Wegovy in the coming months, and will largely shift its weight-loss offerings to older generic pills.Hims sold $225 million worth of its Wegovy knockoff last year, and wants to parlay that into a durable weight-loss medicine business over the coming years.That raises the stakes as the shortages end, and patients begin to look for alternatives for the compounded versions on which they had been relying. If Novo Nordisk and Lilly can capt","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689472784.USD","IE00B2B36J28.USD","LU0708995401.HKD","BK4007","BK4585","BK4599","LU1093756325.SGD","SG9999014880.SGD","HIMS","SGXZ57979304.SGD","LU0198837287.USD","SGXZ51526630.SGD","LU0354030511.USD","SG9999014914.USD","IE00BJT1NW94.SGD","LU0079474960.USD","LU0466842654.USD","LU0672654240.SGD","LU1868837136.USD","BK4533","LU1548497426.USD","NVO","SG9999018865.SGD","LU0256863811.USD","LU0114720955.EUR","LU0385154629.USD","LU1712237335.SGD","LU0096364046.USD","LU1868836914.USD","LU0320765059.SGD","LU0471298694.HKD","IE00BK4W5M84.HKD","LU2360106947.USD","LU1623119135.USD","LU1868836591.USD","IE00BJJMRZ35.SGD","LU2063271972.USD","LU1988902786.USD","LU2361044949.HKD","IE00BFTCPJ56.SGD","LU2211815571.USD","IE00BK4W5L77.USD","LU1023059063.AUD","LU2357305700.SGD","IE0009355771.USD","LU2361044865.SGD","IE00BKVL7J92.USD","BK4588","LU1035775433.USD"],"gpt_icon":1},{"id":"2517946605","title":"Why Novo Nordisk (NVO) Is Rising Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2517946605","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517946605?lang=en_us&edition=fundamental","pubTime":"2025-03-05 23:37","pubTimestamp":1741189062,"startTime":"0","endTime":"0","summary":"Novo Nordisk  is advancing 4% after the drug maker cut the price of its very popular weight-loss drug, Wegovy, by over 50%. Additionally, the company launched a new online pharmacy from which the drug can be obtained.The news caused Hims & Hers  to sink 9%. HIMS sells lower-cost compounds that incorporate the same active ingredient as Wegovy.Novo Nordisk announced that it planned to start selling all doses of Wegovy for $499 per month, versus the current list price of $1,349 for a 28-day supply.The firm also noted that it had started NovoCare Pharmacy which it called \"a direct-to-patient delivery option that offers cash-paying patients all dose strengths of Wegovy.\". \"With NovoCarePharmacy, patients and prescribers alike have another option that provides convenient access to all doses of real, FDA-approved Wegovy at a reduced cost in our high-quality pen,\" Dave Moore, Executive Vice President, U.S. Operations and Global Business Development and President of Novo Nordisk said in a state","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-novo-nordisk-nvo-rising-153742453.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4599","BK4588","BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","IE00BZ1G4Q59.USD","NVO","LU0154236417.USD","BK4007","LU1093756168.USD","BK4196","BK4532"],"gpt_icon":1},{"id":"2517948007","title":"Novo Nordisk Launches NovoCare Pharmacy to Ship Wegovy Doses to Users' Homes","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948007","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517948007?lang=en_us&edition=fundamental","pubTime":"2025-03-05 22:57","pubTimestamp":1741186620,"startTime":"0","endTime":"0","summary":"Novo Nordisk launched NovoCare Pharmacy, to deliver doses of its weight-loss Wegovy drug directly to its users, in a bid to reduce its cost.The Danish pharmaceutical company said Wednesday that the new direct-to-patient delivery option will allow Wegovy users to receive all dose strengths of the drug at a reduced cost of $499 per month.Uninsured patients and those with insurance that doesn't cover obesity drugs would also be able to make use of this offer, the group said.NovoCare Pharmacy arrives at a time of increased competition in the booming market for weight-loss drugs, still led by Eli Lilly and Novo Nordisk, which nonetheless are seeing smaller rivals such as Roche, Pfizer and Amgen striving to challenge them.The announcement comes a couple of weeks after the U.S. Food and Drug Administration declared that the shortage of Novo Nordisk's blockbuster GLP-1 drugs, Wegovy and Ozempic, had been resolved.All dose strengths of Wegovy are either meeting or surpassing current and project","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","BK4599","LU1066053197.SGD","BK4533","BK4581","LU0985481810.HKD","LU1057294990.SGD","LU1894683348.USD","BK4592","LU1883839398.USD","IE00BZ1G4Q59.USD","SG9999001176.SGD","SG9999001176.USD","BK4585","LU1093756168.USD","SG9999003800.SGD","LU1023059063.AUD","LU0289739699.SGD","LU1093756325.SGD","IE0002270589.USD","LU0058720904.USD","BK4532","LU0154236417.USD","IE00B19Z3581.USD","LU0225284248.USD","IE000M9KFDE8.USD","LU1066051498.USD","SG9999002232.USD","LU0306807586.USD","LU0868494617.USD","LU0234572021.USD","BK4007","BK4550","IE00BLSP4239.USD","LU0306806265.USD","SGXZ57979304.SGD","BK4568","LU0321505439.SGD","BK4588","LU0122379950.USD","IE00B19Z3B42.SGD","BK4534","LU1894683264.USD","SG9999011175.SGD","LU0225771236.USD","SG9999013999.USD","IE00BKVL7J92.USD","LU0170899867.USD","NVO"],"gpt_icon":1},{"id":"2517945267","title":"Novo Nordisk Slashes Wegovy Price, Undercutting Hims & Hers Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2517945267","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517945267?lang=en_us&edition=fundamental","pubTime":"2025-03-05 22:51","pubTimestamp":1741186306,"startTime":"0","endTime":"0","summary":"Novo Nordisk slashed the price of Wegovy by more than half on Wednesday amid a bitter rivalry with Hims & Hers Health.","market":"fut","thumbnail":"https://www.investors.com/wp-content/uploads/2019/09/stock-NovoNordisk-02-shutter-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2019/09/stock-NovoNordisk-02-shutter-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/novo-nordisk-wegovy-price-cut-hims-stock/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["LU1093756325.SGD","BK4585","BK4599","IE00BKVL7J92.USD","LU0154236417.USD","LU1093756168.USD","IE00BZ1G4Q59.USD","HIMS","NVO","BK4196","NVO.AU","BK7104","BK4007","BK4588","BK4532"],"gpt_icon":1},{"id":"2517484249","title":"German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2517484249","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517484249?lang=en_us&edition=fundamental","pubTime":"2025-03-05 22:42","pubTimestamp":1741185765,"startTime":"0","endTime":"0","summary":"German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patentFRANKFURT, March 5  - A German court in Duesseldorf on Wednesday ruled that Pfizer PFE.N and its partner BioNTech 22UAy.DE violated a COVID-19 vaccine patent held by Moderna MRNA.O.In a statement, the court said that Pfizer and BioNTech would have to provide information on earnings derived from the use of the patent and that they owe Moderna appropriate compensation, though the ruling can still be appealed to a higher court.  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nS8N3GY070:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","LU0456855351.SGD","IE00BBT3K403.USD","BK4588","IE00B19Z3B42.SGD","BK4139","BK4550","SG9999002232.USD","BK4581","BK4007","IE00BLSP4452.SGD","LU1894683264.USD","IE0002270589.USD","BK4533","LU0225771236.USD","LU1057294990.SGD","IE000M9KFDE8.USD","PFE","SG9999003800.SGD","MRNA","BK4532","LU1066051498.USD","IE00BLSP4239.USD","BK4501","IE00B19Z3581.USD","LU1894683348.USD","SG9999002224.SGD","BK4551","LU0306806265.USD","BK4585","BK4568","LU0234572021.USD","SG9999013999.USD","LU0122379950.USD","SGXZ57979304.SGD","SG9999011175.SGD","BK4534","LU1066053197.SGD","LU0289739699.SGD","BK4548","LU0868494617.USD","LU1883839398.USD","SG9999001176.SGD","LU0306807586.USD","BK4592","SG9999001176.USD","LU1023059063.AUD","LU0170899867.USD","LU0321505439.SGD","BK4599"],"gpt_icon":1},{"id":"2517910906","title":"German Court Rules in Favour of Moderna in Patent Lawsuit Against BioNTech and Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910906","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517910906?lang=en_us&edition=fundamental","pubTime":"2025-03-05 22:39","pubTimestamp":1741185576,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nS8N3GY070:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LU0225284248.USD","SG9999011175.SGD","BK4533","LU0289739699.SGD","LU1883839398.USD","LU0225771236.USD","SG9999002224.SGD","MRNA","LU0058720904.USD","BK4585","IE000M9KFDE8.USD","LU1066053197.SGD","LU1023059063.AUD","PFE","IE00BBT3K403.USD","IE00B19Z3B42.SGD","LU0321505868.SGD","SG9999003800.SGD","LU0456855351.SGD","SG9999013999.USD","BK4599","IE0002270589.USD","LU0306807586.USD","BK4532","IE00BLSP4239.USD","IE00BLSP4452.SGD","BK4548","SG9999002232.USD","BK4139","LU0985481810.HKD","LU1057294990.SGD","LU1066051498.USD","LU0234572021.USD","SGXZ57979304.SGD","BK4550","BK4592","BK4534","LU0306806265.USD","LU1894683264.USD","LU0321505439.SGD","LU1894683348.USD","IE00B19Z3581.USD","LU0170899867.USD","BK4568","SG9999001176.USD","LU0122379950.USD","BK4501","SG9999001176.SGD","BK4588"],"gpt_icon":0},{"id":"2517910406","title":"Court Rules Pfizer, BioNTech Must Pay \"Appropriate\" Damages and Compensation; Ruling Can Be Appealed","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910406","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517910406?lang=en_us&edition=fundamental","pubTime":"2025-03-05 22:39","pubTimestamp":1741185576,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nS8N3GY070:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRNA","LU1057294990.SGD","LU1023059063.AUD","SG9999002232.USD","LU0456855351.SGD","BK4581","BK4548","LU0234572021.USD","LU0868494617.USD","LU1066053197.SGD","IE00BBT3K403.USD","LU0225284248.USD","LU0306807586.USD","LU0985481810.HKD","IE000M9KFDE8.USD","LU1894683348.USD","LU0306806265.USD","LU0170899867.USD","SG9999011175.SGD","BK4550","BK4588","LU0289739699.SGD","LU0058720904.USD","BK4501","LU1894683264.USD","SGXZ57979304.SGD","LU0225771236.USD","SG9999003800.SGD","LU0122379950.USD","BK4585","IE00BLSP4452.SGD","BK4568","PFE","BK4532","IE00BLSP4239.USD","IE00B19Z3B42.SGD","BK4139","BK4551","SG9999001176.USD","BK4534","BK4533","BK4599","LU0321505868.SGD","SG9999013999.USD","SG9999001176.SGD","BK4007","LU1883839398.USD","IE00B19Z3581.USD","IE0002270589.USD","LU1066051498.USD"],"gpt_icon":0},{"id":"2517499679","title":"Novo Nordisk Plunges 21% in 3 Months: Buy, Sell or Hold the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517499679","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517499679?lang=en_us&edition=fundamental","pubTime":"2025-03-05 22:18","pubTimestamp":1741184280,"startTime":"0","endTime":"0","summary":"Novo NordiskNVO shares have lost 21% in the past three months against the industry’s growth of 4.6%. The company has also underperformed in the sector and the S&P 500 during the same time frame, as seen in the chart below. The stock is currently trading above its 50-day moving average but below its 200-day moving average.NVO Stock Underperforms the Industry, Sector & the S&P 500. The company has a strong presence in the Diabetes care market, with one of the broadest diabetes portfolios in the industry. The company has maintained its global diabetes value market share over the past year at 33.7%, fueled by Rybelsus, Ozempic and Victoza, putting up a strong performance. In 2024, Novo Nordisk’s GLP-1 sales in diabetes increased 21%, depicting greater patient outreach and market capture by its GLP-1 products. Novo Nordisk continues to be the global m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novo-nordisk-plunges-21-3-141800742.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0943347566.SGD","LU1988902786.USD","LU2324357040.USD","SG9999001440.SGD","LU1720051108.HKD","LU1023059063.AUD","LU0354030511.USD","IE00BFTCPJ56.SGD","LU0061475181.USD","IE00B2B36J28.USD","LU1804176565.USD","LU2265009873.SGD","LU0456855351.SGD","LU0154236417.USD","LU0820561909.HKD","LU2237438978.USD","LU0320765992.SGD","LU0385154629.USD","LU1868836914.USD","LU0320765059.SGD","LU0094547139.USD","LU1057294990.SGD","IE0004445239.USD","SG9999014880.SGD","BK4532","BK4599","SG9999015986.USD","LU1064131342.USD","SGXZ31699556.SGD","AMGN","VKTX","IE00BJT1NW94.SGD","LU0868494617.USD","LU2361045086.USD","SG9999017495.SGD","LU0058720904.USD","LLY","BK4516","LU0708995401.HKD","LU1548497426.USD","LU2063271972.USD","LU0640476718.USD","LU1974910355.USD","NVO","IE00BJLML261.HKD","LU2237443622.USD","LU2468319806.SGD","LU0097036916.USD","BK4581","LU2089984988.USD"],"gpt_icon":1},{"id":"2517948893","title":"GM, Novo Nordisk, Marvell, CrowdStrike: Stocks to watch today","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948893","media":"Quartz","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517948893?lang=en_us&edition=fundamental","pubTime":"2025-03-05 22:06","pubTimestamp":1741183560,"startTime":"0","endTime":"0","summary":"U.S. stock futures edged higher early Wednesday, recovering slightly from this week’s selloff as Commerce Secretary Howard Lutnick talked about potential tariff relief for Canada and Mexico, hinting that the U.S. could find a compromise “in the middle.”S&P 500 futures gained 0.05%, while Nasdaq 100 futures added 0.2%. Dow Jones Industrial Average futures were hovering slightly above the flatline.CrowdStrike  stock fell almost 7% in pre-market trading on Wednesday after the cybersecurity software company provided disappointing earnings guidance. The company gained significant attention last year following a widespread global tech outage linked to its software.General Motors  stock surged more than 5% in early trading as the broader market rebounded. The rally appeared to be driven by investor optimism following Lutnick’s remarks suggesting potential tariff relief for Canada and Mexico.Shares of Novo Nordisk  climbed 4% in pre-market trading after the company announced plans to sell its ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gm-novo-nordisk-marvell-crowdstrike-140600090.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1084165304.USD","BK4528","LU2125909916.SGD","LU0006061336.USD","LU1548497426.USD","LU2264538146.SGD","MRVL","GM","LU1989764664.SGD","BK4559","LU1988902786.USD","LU0130103400.USD","IE00BZ9MQY76.HKD","IE00BMPRXN33.USD","LU1303367103.USD","LU0127658192.USD","LU2357305700.SGD","LU1093756168.USD","LU1989764748.USD","LU2125909247.SGD","LU2106854487.HKD","LU0642271901.SGD","BK4599","LU1951198990.SGD","LU2473716301.USD","BK4141","LU2433249047.HKD","BK4551","LU1852331112.SGD","LU1720051108.HKD","LU0130102774.USD","BK4532","BK4555","LU0320765489.SGD","LU0477156953.USD","LU1169590202.USD","IE00BKVL7J92.USD","LU1992135472.HKD","BK4099","BK4605","NVO","IE00BZ1G4Q59.USD","LU1316542783.SGD","LU0061475181.USD","IE00B894F039.SGD","LU0162691827.USD","LU2125909759.SGD","LU1861215975.USD","CRWD","LU1720051017.SGD"],"gpt_icon":1},{"id":"2517173679","title":"Novo Nordisk offers Wegovy at lowered cost, Hims & Hers Health shares fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2517173679","media":"Investing.com","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517173679?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:50","pubTimestamp":1741182603,"startTime":"0","endTime":"0","summary":"Investing.com -- Novo Nordisk  is introducing NovoCare Pharmacy, a direct-to-patient delivery option offering Wegovy at a reduced price of $499 per month for certain cash-paying patients.The program is available to uninsured individuals and those with commercial insurance that does not cover obesity medicines, expanding access to the company’s blockbuster weight-loss drug.The announcement weighed on shares of Hims Hers Health Inc , a telehealth provider that offers compounded versions of weight-loss drugs, which fell around 3% in premarket trading Wednesday.The move follows the FDA’s recent announcement that the supply shortage of Wegovy has been resolved, with all dose strengths now meeting or exceeding demand.By offering direct home delivery through CenterWell Pharmacy, Novo Nordisk aims to streamline patient access while reducing reliance on retail pharmacies. The company is also providing support services such as benefit verification, refill reminders, and live case management.\"Nov","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novo-nordisk-offers-wegovy-lowered-135003561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4588","IE00BKVL7J92.USD","HIMS","LU0154236417.USD","BK4585","LU1093756168.USD","NVO","LU1093756325.SGD","BK4599","BK4196","IE00BZ1G4Q59.USD","BK4532"],"gpt_icon":1},{"id":"2517891465","title":"Novo Nordisk Launches Delivery Option Offering Lower-Priced Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=2517891465","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517891465?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:29","pubTimestamp":1741181366,"startTime":"0","endTime":"0","summary":"Novo Nordisk  said Wednesday it is offering cash-paying patients all dose strengths of Wegovy at a lower price of $499 per month through a direct-to-patient delivery option called NovoCare Pharmacy.The company said NovoCare Pharmacy expands its offerings to meet the needs of people living with obesity, following the recent decision of the US Food and Drug Administration that the shortage of the medicine has been resolved.Uninsured patients or eligible patients with commercial insurance who don't have coverage for obesity medicines can avail of the offer, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO","LU1093756168.USD","IE00BZ1G4Q59.USD","BK4532","BK4007","BK4599","BK4588","BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","LU0154236417.USD","NVO.AU","BK7104"],"gpt_icon":1},{"id":"2517914883","title":"Kenvue Announces Three New Appointments to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2517914883","media":"Business Wire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517914883?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:05","pubTimestamp":1741179900,"startTime":"0","endTime":"0","summary":"Company and Starboard Value LP Enter into Cooperation Agreement. SKILLMAN, N.J., March 05, 2025----Kenvue Inc. , the world’s largest pure-play consumer health company by revenue, today announced the appointment of two new independent directors, Sarah Hofstetter, President of Profitero, Ltd., and Erica Mann, former President and Head of Bayer’s Consumer Health Division, to the Company’s Board of Directors . Additionally, Jeffrey Smith, Managing Member, Chief Executive Officer and Chief Investment Officer of Starboard Value LP  will join the Board. All three appointments are effective immediately.\"We invested in Kenvue because of the tremendous potential we see in the Company’s portfolio of iconic brands and market-leading positions in large and growing markets. I am pleased to join the Board along with Sarah and Erica following the constructive dialogue we had with the Board and management team. We look forward to working collectively as a Board to position Kenvue as the preeminent glob","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kenvue-announces-three-appointments-board-130500182.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0868494617.USD","LU1057294990.SGD","LU0321505439.SGD","IE00B19Z3581.USD","KVUE","IE00BLSP4239.USD","BK4534","SG9999001176.SGD","BK4007","LU0058720904.USD","LU0306806265.USD","SG9999013999.USD","IE000M9KFDE8.USD","BK4533","SG9999002224.SGD","BK4183","SG9999011175.SGD","LU0289739699.SGD","LU1894683264.USD","IE00B19Z3B42.SGD","LU0225284248.USD","IE00BLSP4452.SGD","SG9999002232.USD","LU0225771236.USD","BK4599","BK4588","LU0456855351.SGD","LU1023059063.AUD","SGXZ57979304.SGD","BK4585","SG9999003800.SGD","BK4550","IE0002270589.USD","LU1066051498.USD","LU0985481810.HKD","LU1066053197.SGD","LU1894683348.USD","LU0306807586.USD","LU0321505868.SGD","SG9999001176.USD","IE00BFXG1179.USD","BK4592","LU0234572021.USD","BK4581","LU1883839398.USD","LU0170899867.USD","IE00B3T34201.USD","LU0122379950.USD","IE00BBT3K403.USD"],"gpt_icon":1}],"pageSize":16,"totalPage":14,"pageCount":2,"totalSize":218}]}}